Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
DRUG
NPCE
Add up to 3 more stocks
DRUG
Bright Minds Biosciences Inc.
-2.51%
$48.54-1.25Delayed quote: Oct 6, 2026, 3:00 PM EDT
Market Cap
$475.07M
52W Range
$48.53 - $123.75
NPCE
NeuroPace, Inc.
-1.89%
$12.97-0.25Delayed quote: Oct 6, 2026, 2:54 PM EDT
Market Cap
$442.20M
52W Range
$9.22 - $19.60
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.19 | 37.21 |
| P/S Ratio | N/A | 4.47 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 79.6% |
| Operating Margin | 0.0% | -15.3% |
| Net Margin | 0.0% | -19.3% |
| ROE | -8.2% | -160.8% |
| ROA | -8.1% | -19.7% |
| ROIC | -13.2% | -18.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 121.97 | 4.94 |
| Quick Ratio | 121.97 | 3.91 |
| Debt/Equity | 0.00 | 5.88 |
| Interest Coverage | N/A | -2.19 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.